IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 154 filers reported holding IVERIC BIO INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,562,073 | +203.0% | 39,707 | +87.4% | 0.00% | +200.0% |
Q1 2023 | $515,455 | +34.0% | 21,186 | +17.9% | 0.00% | 0.0% |
Q4 2022 | $384,695 | +14.2% | 17,968 | -4.3% | 0.00% | 0.0% |
Q3 2022 | $337,000 | +30.6% | 18,774 | -30.0% | 0.00% | 0.0% |
Q2 2022 | $258,000 | -44.0% | 26,821 | -2.2% | 0.00% | 0.0% |
Q1 2022 | $461,000 | -67.4% | 27,420 | -67.6% | 0.00% | -66.7% |
Q4 2021 | $1,415,000 | +126.4% | 84,609 | +120.0% | 0.00% | +200.0% |
Q3 2021 | $625,000 | +168.2% | 38,458 | +2.1% | 0.00% | – |
Q1 2021 | $233,000 | -80.3% | 37,657 | -77.9% | 0.00% | -100.0% |
Q4 2020 | $1,180,000 | +60.1% | 170,720 | +30.6% | 0.00% | +100.0% |
Q3 2020 | $737,000 | – | 130,732 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |